Statin therapy considered for thyroid eye disease

VANCOUVER, British Columbia — Statins show promise as a low-risk disease-modifying agent for treating thyroid eye disease, for which smoking is seen as the only modifiable risk factor. A hyperosmotic shift of fluid into orbital tissue is associated with thyroid eye disease, and the resultant inflammatory state can last for 1 to 2 years, Andrew L. Reynolds, MD, said at the American Association for Pediatric Ophthalmology and Strabismus meeting

Study quantifies significant time spent documenting in EHRs

VANCOUVER, British Columbia — Like in other ophthalmic specialties, a significant amount of the pediatric ophthalmologist’s time is spent documenting in electronic health records, perhaps detrimentally so, according to a study presented here.“There’s been a lot of anecdotal and some published evidence showing that there may be a negative impact of EHRs on efficiency by ophthalmologists,” Michael F. Chiang, MD, said at the American Association for Pediatric Ophthalmology and Strabismus meeting.

Research suggests new pathway for preventing optic nerve damage in KPro recipients

Researchers from Massachusetts Eye and Ear/Harvard Medical School have identified inflammatory factors that cause optic neuropathy in the back of the eye following implantation of a keratoprosthesis (KPro) — similar to what glaucoma patients experience, without the rise of pressure in the eye — and have shown that blocking one of those factors, tumor necrosis factor alpha (TNFa), successfully halts the development of optic nerve damage in a mouse model.